Non-Hodgkin's lymphoma of the brain after Hodgkin's disease. An immunohistochemical study
โ Scribed by Robertson D. Davenport; Loretta R. O'Donnell; Bertram Schnitzer; Paul E. McKeever
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 475 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Non-Hodgkin's lymphoma (NHL) of the central nervous system (CNS) is a rarely reported complication of Hodgkin's disease (HD). Two patients with NHL of the brain after HD were studied by histologic and immunohistochemical methods. Both patients were in the second decade, had been treated with radiation and chemotherapy, had experienced a relapse of HD before development of NHL, had no evidence of HD at the time of diagnosis of NHL, and died within 1 year of diagnosis. Both brain neoplasms were large cell immunoblastic lymphomas of B-cell lineage. Patients with HD appear to be at increased risk for NHL of the CNS, which may have a poor prognosis. Cancer 67:440-443,1991.
ODGKIN'S DISEASE (HD) rarely involves the central H nervous system (CNS). In contrast, non-Hodgkin's lymphomas (NHL) of the CNS, although in the minority of primary CNS neoplasms, are increasingly common and frequently occur in immunologically compromised patients.l,2 Patients with HD are at increased risk of developing second malignancies, including NHL,3-5 although CNS lymphomas have rarely been
We studied two patients who had primary NHL of the brain after HD. These cases share many clinical and pathologic features, suggesting that NHL of the CNS and HD may be causally related.
๐ SIMILAR VOLUMES
This article describes four cases of non-Hodgkin's lymphomas occurring after successful treatment of Hodgkin's disease (HD). The clinical symptoms consisted of digestive disorders, and the histology confirmed an intestinal involvement in these four patients. In all cases patients had diffuse large c
Much of the approach to evaluation and management of the non-Hodgkin's lymphomas has been modeled after Hodgkin's disease. However, as the name implies, they are quite different. The non-Hodgkin's lymphomas are a group of diseases and syndromes. These many different presentations, syndromes, and pos
Recent studies specifically directed toward assessing the outcome of older patients with non-Hodgkin's lymphoma (NHL) indicate that age per se is an important and independent prognostic factor for response and survival. We report a review of the clinical trials of the literature and the Aviano Group